Approval · Notice of Compliance 2948 · 2004
DEFINITY: Notice of Compliance 2948
Issued May 17, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2948
- Date
- May 17, 2004
- Company
- Bristol-Myers Squibb CanadaSt-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New formulation: addition of a phosphate buffer
- Therapeutic class
- Contrast enhancing imaging agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DEFINITY | Not yet assigned | — |
Medicinal ingredients
- PERFLUTREN 150 MCL per ML